Ajanta Pharma Limited

NSE:AJANTPHARM India Drug Manufacturers - Specialty & Generic
Market Cap
$4.50 Billion
₹389.74 Billion INR
Market Cap Rank
#5812 Global
#201 in India
Share Price
₹3119.50
Change (1 day)
+2.34%
52-Week Range
₹2374.45 - ₹3119.50
All Time High
₹3395.67
About

Ajanta Pharma Limited, together with its subsidiaries, a pharmaceutical formulation company that develops, manufactures, and markets specialty pharmaceutical finished dosages. The company offers chronic and acute therapies; branded generic products; and a range of dosage forms, including tablets, capsules, injectables, inhalers, ointments, creams, and liquids. It also serves various therapeutic a… Read more

Ajanta Pharma Limited (AJANTPHARM) - Total Liabilities

Latest total liabilities as of September 2025: ₹13.57 Billion INR

Based on the latest financial reports, Ajanta Pharma Limited (AJANTPHARM) has total liabilities worth ₹13.57 Billion INR as of September 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Ajanta Pharma Limited - Total Liabilities Trend (2005–2025)

This chart illustrates how Ajanta Pharma Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Ajanta Pharma Limited Competitors by Total Liabilities

The table below lists competitors of Ajanta Pharma Limited ranked by their total liabilities.

Company Country Total Liabilities
Laboratorios Farmaceuticos Rovi S.A
PINK:LABFF
USA $289.27 Million
Xinxing Ductile Iron Pipes Co Ltd
SHE:000778
China CN¥24.99 Billion
PACS Group, Inc.
NYSE:PACS
USA $4.75 Billion
Chongqing Brewery Co Ltd
SHG:600132
China CN¥8.95 Billion
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
China CN¥1.04 Billion
Carmila SA
PA:CARM
France €3.29 Billion
Hyundai Elevator
KO:017800
Korea ₩2.16 Trillion
Fujian Snowman Co Ltd
SHE:002639
China CN¥2.40 Billion

Liability Composition Analysis (2005–2025)

This chart breaks down Ajanta Pharma Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.93 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 0.00 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.31 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.24 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Ajanta Pharma Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Ajanta Pharma Limited (2005–2025)

The table below shows the annual total liabilities of Ajanta Pharma Limited from 2005 to 2025.

Year Total Liabilities Change
2025-03-31 ₹12.25 Billion +14.34%
2024-03-31 ₹10.71 Billion -17.04%
2023-03-31 ₹12.91 Billion +63.17%
2022-03-31 ₹7.91 Billion +1.04%
2021-03-31 ₹7.83 Billion +8.79%
2020-03-31 ₹7.20 Billion +59.62%
2019-03-31 ₹4.51 Billion +10.74%
2018-03-31 ₹4.07 Billion +59.68%
2017-03-31 ₹2.55 Billion -17.57%
2016-03-31 ₹3.09 Billion +1.35%
2015-03-31 ₹3.05 Billion -14.26%
2014-03-31 ₹3.56 Billion +9.51%
2013-03-31 ₹3.25 Billion -7.32%
2012-03-31 ₹3.51 Billion +19.58%
2011-03-31 ₹2.93 Billion -5.43%
2010-03-31 ₹3.10 Billion +1.44%
2009-03-31 ₹3.06 Billion +36.04%
2008-03-31 ₹2.25 Billion +47.15%
2007-03-31 ₹1.53 Billion +15.49%
2006-03-31 ₹1.32 Billion +11.06%
2005-03-31 ₹1.19 Billion --